{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:24:56Z","timestamp":1767849896744,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ogc.2022.10.007","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:04:29Z","timestamp":1677017069000},"page":"121-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Medications for Managing Preexisting and Gestational Diabetes in Pregnancy"],"prefix":"10.1016","volume":"50","author":[{"given":"Michaela","family":"Rickert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron B.","family":"Caughey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy M.","family":"Valent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"43","key":"10.1016\/j.ogc.2022.10.007_bib1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.15585\/mmwr.mm6743a2","article-title":"Prevalence and Changes in Preexisting Diabetes and Gestational Diabetes Among Women Who Had a Live Birth - United States, 2012-2016","volume":"67","author":"Deputy","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.007_bib2","doi-asserted-by":"crossref","first-page":"654.e1","DOI":"10.1016\/j.ajog.2010.04.006","article-title":"The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus","volume":"202","author":"Coustan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2022.10.007_bib3","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.01.041","article-title":"SMFM Statement: Pharmacological treatment of gestational diabetes","volume":"218","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2022.10.007_bib4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1515\/jpm-2021-0247","article-title":"Prediction of insulin therapy in women with gestational diabetes: a systematic review and meta-analysis of observational studies","volume":"50","author":"Alvarez-Silvares","year":"2022","journal-title":"J\u00a0Perinat Med"},{"issue":"17","key":"10.1016\/j.ogc.2022.10.007_bib5","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1080\/14767058.2018.1449203","article-title":"Which criteria should be used for starting pharmacologic therapy for management of gestational diabetes in pregnancy? Evidence from randomized controlled trials","volume":"32","author":"Caissutti","year":"2019","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"16","key":"10.1016\/j.ogc.2022.10.007_bib6","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A\u00a0comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2022.10.007_bib7","doi-asserted-by":"crossref","first-page":"h102","DOI":"10.1136\/bmj.h102","article-title":"Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis","volume":"350","author":"Balsells","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ogc.2022.10.007_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4103\/ijmr.IJMR_1572_16","article-title":"Metformin in gestational diabetes mellitus","volume":"145","author":"Tripathi","year":"2017","journal-title":"Indian J Med Res"},{"issue":"10110","key":"10.1016\/j.ogc.2022.10.007_bib9","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.007_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0038-1676510","article-title":"Effectiveness of Insulin Analogs Compared with Human Insulins in Pregnant Women with Diabetes Mellitus: Systematic Review and Meta-analysis","volume":"41","author":"Santos","year":"2019","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.007_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc06-1887","article-title":"Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women","volume":"30","author":"Mathiesen","year":"2007","journal-title":"Diabetes Care"},{"issue":"2 Pt 2","key":"10.1016\/j.ogc.2022.10.007_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/AOG.0b013e31824fd27d","article-title":"Pregestational diabetes with extreme insulin resistance: use of U-500 insulin in pregnancy","volume":"120","author":"Zuckerwise","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.007_bib13","doi-asserted-by":"crossref","first-page":"426.e1","DOI":"10.1016\/j.ajog.2015.06.010","article-title":"Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes","volume":"213","author":"Herrera","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.007_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1345\/aph.1P327","article-title":"Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis","volume":"45","author":"Pollex","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.007_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13300-018-0532-z","article-title":"Successful outcomes with insulin degludec in pregnancy: a case series","volume":"10","author":"Hiranput","year":"2019","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.007_bib16","doi-asserted-by":"crossref","first-page":"367.e1","DOI":"10.1016\/j.ajog.2018.06.013","article-title":"A\u00a0cautionary response to SMFM statement: pharmacological treatment of gestational diabetes","volume":"219","author":"Barbour","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ogc.2022.10.007_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"19","key":"10.1016\/j.ogc.2022.10.007_bib18","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ogc.2022.10.007_bib19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/00365513.2012.712319","article-title":"Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero","volume":"72","author":"R\u00f8","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.007_bib20","doi-asserted-by":"crossref","first-page":"e000456","DOI":"10.1136\/bmjdrc-2017-000456","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age","volume":"6","author":"Rowan","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"8","key":"10.1016\/j.ogc.2022.10.007_bib21","doi-asserted-by":"crossref","first-page":"e1002848","DOI":"10.1371\/journal.pmed.1002848","article-title":"Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis","volume":"16","author":"Tarry-Adkins","year":"2019","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.ogc.2022.10.007_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/dmd.109.031245","article-title":"Pharmacokinetics of metformin during pregnancy","volume":"38","author":"Eyal","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.007_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mcp.2003.9","article-title":"Transfer of metformin into human milk","volume":"73","author":"Gardiner","year":"2003","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.007_bib24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00125-002-0939-x","article-title":"Transfer of metformin into human milk","volume":"45","author":"Hale","year":"2002","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.007_bib25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/01.AOG.0000163249.65810.5b","article-title":"Excretion of metformin into breast milk and the effect on nursing infants","volume":"105","author":"Briggs","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.007_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jcpt.13503","article-title":"The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: A systematic review and meta-analysis of 21 randomized controlled trials","volume":"47","author":"He","year":"2022","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"5","key":"10.1016\/j.ogc.2022.10.007_bib27","doi-asserted-by":"crossref","first-page":"e64585","DOI":"10.1371\/journal.pone.0064585","article-title":"Metformin vs insulin in the management of gestational diabetes: a meta-analysis","volume":"8","author":"Gui","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.007_bib28","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1210\/jc.2010-0449","article-title":"Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction","volume":"95","author":"Zeller","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"38","key":"10.1016\/j.ogc.2022.10.007_bib29","doi-asserted-by":"crossref","first-page":"e7939","DOI":"10.1097\/MD.0000000000007939","article-title":"Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.007_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/AOG.0b013e31829007f0","article-title":"A\u00a0pharmacologic approach to the use of glyburide in pregnancy","volume":"121","author":"Caritis","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.007_bib31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ajog.2006.07.029","article-title":"Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes","volume":"195","author":"Rochon","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.007_bib32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.diabres.2006.09.031","article-title":"A\u00a0prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women","volume":"76","author":"Anjalakshi","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.007_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijgo.2010.04.028","article-title":"Metformin compared with glyburide for the management of gestational diabetes","volume":"111","author":"Silva","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2022.10.007_bib34","doi-asserted-by":"crossref","first-page":"eRW6155","DOI":"10.31744\/einstein_journal\/2022RW6155","article-title":"Metformin versus glyburide in treatment and control of gestational diabetes mellitus: a systematic review with meta-analysis","volume":"20","author":"Oliveira","year":"2022","journal-title":"Einstein (Sao Paulo)."},{"issue":"8","key":"10.1016\/j.ogc.2022.10.007_bib35","doi-asserted-by":"crossref","first-page":"e0182488","DOI":"10.1371\/journal.pone.0182488","article-title":"Comparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis","volume":"12","author":"Song","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.007_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1345\/aph.1K577","article-title":"Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes","volume":"42","author":"Moretti","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.007_bib37","doi-asserted-by":"crossref","first-page":"e225026","DOI":"10.1001\/jamanetworkopen.2022.5026","article-title":"Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes","volume":"5","author":"Hedderson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.007_bib38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/01.AOG.0000218704.28313.36","article-title":"Predictors of glyburide failure in the treatment of gestational diabetes","volume":"107","author":"Kahn","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.007_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/14767058.2011.580402","article-title":"Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes","volume":"25","author":"Cheng","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.007_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0041-1739266","article-title":"Correlates of Insulin Selection as a First-Line Pharmacological Treatment for Gestational Diabetes","volume":"39","author":"Palatnik","year":"2022","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ogc.2022.10.007_bib41","series-title":"Acarbose. StatPearls","author":"McIver","year":"2022"},{"issue":"12","key":"10.1016\/j.ogc.2022.10.007_bib42","first-page":"e12283","article-title":"Comparison of fetomaternal outcomes in patients with gestational diabetes mellitus treated with insulin versus acarbose: results of a prospective, open label, controlled study","volume":"12","author":"Jayasingh","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.007_bib43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000515893","article-title":"Comparison of insulin, metformin, and glyburide on perinatal complications of gestational diabetes mellitus: a systematic review and meta-analysis","volume":"86","author":"Wang","year":"2021","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.007_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00125-011-2363-6","article-title":"Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy","volume":"55","author":"Murphy","year":"2012","journal-title":"Diabetologia"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854522000985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854522000985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:26:03Z","timestamp":1760178363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854522000985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0889854522000985"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2022.10.007","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medications for Managing Preexisting and Gestational Diabetes in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2022.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}